İBRAHİM HALİL YAVUZ, GÖKNUR ÖZAYDIN YAVUZ, SERAP GÜNEŞ BİLGİLİ, İRFAN BAYRAM, Hülya SAVAŞ

Erythema multiforme; sixty six case series with review of literature

Erythema multiforme (EM) is an acute, self-limited, and sometimes recurrent skin disease considered to be a hypersensitivity reaction associated with certain medications and infections. EM has recently been recognized as a distinct disease differentiated from the Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). The aim of this study was to evaluate the clinical and histopathological characteristics of patients with EM. The retrospective study included 66 patients who received outpatient or inpatient treatment at the Dermatology department due to a diagnosis of EM between 2005 and 2017. Age, gender, etiological factor, recurrence, significant histopathological findings, presence of target lesions, mucosal involvement, and treatment metho ds were recorded. The 66 patients included 22 (33.3%) men and 44 (66.7%) women with a mean age of 36.7±13.9 years. The etiological factor was Herpes labialis in 36.4%, medication in 31.8%, Orf infection in 13.6%, and no etiological factor was detected in 18.2% of the patients. Although EM is a common entity in dermatology practice, there are a limited number of studies reporting on EM. The results indicated that EM can occur secondary to Orf infection.

PDF

___

Lamoreux MR, Sternbach MR, Hsu WT. Erythema multiforme. Am Fam Physician 2006; 74: 1883-1888.

Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T. Current Perspectives on Erythema Multiforme. Clin Rev Allergy Immunol 2018; 54: 177-184.

Samim F, Auluck A, Zed C, Williams PM. Erythema multiforme: a review of epidemiology,pathogenesis, clinical features, and treatment. Dent Clin North Am 2013; 57: 583- 596.

Scully C, Bagan J. Oral mucosal diseases: erythema multiforme. Br J Oral Maxillofac Surg 2008; 46: 90-95.

Manganaro AM. Erythema multiforme. Gen Dent 1996; 44: 164-166.

Sarkar R, Kaur C, Kanwar AJ. Erythema multiforme due to rofecoxib. Dermatology 2002; 204: 304-305.

Kondolot M, Çipe F, Özmen S, Arslan Z, evaluatıon of cases wıth erythema multıforme, Turkhis J Pediatr Dis 2008; 2: 5-10.

Ng PP, Sun YJ, Tan HH, Tan SH. Detection of herpes simplex virus genomic DNA in various subsets of Erythema multiforme by polymerase chain reaction. Dermatology 2003; 207: 349-353.

Shah SN, Chauhan GR, Manjunatha BS, Dagrus K. Drug induced erythema multiforme: two case series with review of literature. J Clin Diagn Res. 2014; 8: ZH01-4.

Shabahang L. Characteristics of adult outpatients with erythema multiforme. Pak J Biol Sci. 2010; 13: 1106-1109.

Joseph RH, Haddad FA, Matthews AL, Maroufi A, Monroe B, Reynolds M. Erythema multiforme after orf virus infection: a report of two cases and literature review. Epidemiol Infect 2015; 143: 385- 390.

Johani KA, Fedele S, Porter SR. Erythema multiforme and related disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103: 642-654.

Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331: 1272- 1285.

Sheridan RL, Schulz JT, Ryan CM, et al. Longterm consequences of toxic epidermal necrolysis in children. Pediatrics 2002; 109: 74-78.

Wetter DA, Davis MD. Recurrent erythema multiforme: clinical characteristics, etiologic associations, and treatment in a series of 48 patients at Mayo Clinic, 2000 to 2007. J Am Acad Dermatol 2010; 62: 45-53.

Sokumbi O, Wetter DA. Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practicing dermatologist. Int J Dermatol 2012; 51: 889-902.

Sanchis JM, Bagán JV, Gavaldá C, Murillo J, Diaz JM. Erythema multiforme: diagnosis, clinical manifestations and treatment in a retrospective study of 22 patients. J Oral Pathol Med 2010; 39: 747-752.